<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Korean J Intern Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Korean J. Intern. Med</journal-id>
      <journal-id journal-id-type="publisher-id">KJIM</journal-id>
      <journal-title-group>
        <journal-title>The Korean Journal of Internal Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1226-3303</issn>
      <issn pub-type="epub">2005-6648</issn>
      <publisher>
        <publisher-name>Korean Association of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">15053049</article-id>
      <article-id pub-id-type="pmc">4531549</article-id>
      <article-id pub-id-type="doi">10.3904/kjim.2004.19.1.70</article-id>
      <article-id pub-id-type="publisher-id">kjim-19-1-70-14</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hemophagocytic Syndrome Associated with Bilateral Adrenal Gland Tuberculosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Shin</surname>
            <given-names>Byung-Chul</given-names>
          </name>
          <degrees>M.D.</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Shin-Woo</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="corresp" rid="c1-kjim-19-1-70-14"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ha</surname>
            <given-names>Sang-Woo</given-names>
          </name>
          <degrees>M.D.</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sohn</surname>
            <given-names>Jong-Won</given-names>
          </name>
          <degrees>M.D.</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Jong-Myung</given-names>
          </name>
          <degrees>M.D.</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Nung-Soo</given-names>
          </name>
          <degrees>M.D.</degrees>
        </contrib>
        <aff id="af1-kjim-19-1-70-14">Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1-kjim-19-1-70-14">Correspondence to: Shin-Woo Kim, M.D., Department of Internal Medicine, Kyungpook National University Hospital, 50, Samduk 2-ga, Chung-gu, Daegu, 700-721, Korea Tel: 82-53-420-6525, Fax: 82-53-424-5542, E-mail:<email>ksw2kms@knu.ac.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2004</year>
      </pub-date>
      <volume>19</volume>
      <issue>1</issue>
      <fpage>70</fpage>
      <lpage>73</lpage>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>8</month>
          <year>2003</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>10</month>
          <year>2003</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2004 The Korean Association of Internal Medicine</copyright-statement>
        <copyright-year>2004</copyright-year>
        <license>
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We report a case of a patient who presented with hemophagocytic syndrome (HPS) and adrenal crisis associated with bilateral adrenal gland tuberculosis, and resulted in a poor outcome. A 50-year-old man was transferred to our hospital from a local clinic due to fever, weight loss, and bilateral adrenal masses. Laboratory findings showed leukopenia, mild anemia, and elevated lactate dehydrogenase. Computed tomography (CT) of the abdomen revealed bilateral adrenal masses and hepatosplenomegaly. CT-guided adrenal gland biopsy showed numerous epithelioid cells and infiltration with caseous necrosis consistent with tuberculosis. Bone marrow aspiration and biopsy showed significant hemophagocytosis without evidence of malignancy, hence HPS associated with bilateral adrenal tuberculosis was diagnosed. During anti-tuberculosis treatment the patient showed recurrent hypoglycemia and hypotension. Rapid ACTH stimulation test revealed adrenal insufficiency, and we added corticosteroid treatment. But pancytopenia, especially thrombocytopenia, persisted and repeated bone marrow aspiration showed continued hemophagocytosis. On treatment day 41 multiple organ failure occurred in the patient during anti-tuberculous treatment and steroid replacement.</p>
      </abstract>
      <kwd-group>
        <kwd>Histiocytosis</kwd>
        <kwd>Tuberculosis</kwd>
        <kwd>Adrenal glands</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Hemophagocytic syndrome (HPS) is an unusual disorder characterized by a benign proliferation of mature histiocytes and an uncontrolled phagocytosis of some hematic precursors in the bone marrow. Known causes of HPS include infections, tumors, drugs, autoimmune diseases, and other immunosuppressive states<sup><xref rid="b1-kjim-19-1-70-14" ref-type="bibr">1</xref>)</sup>. Various infections can activate macrophages or T-cells, and the overproduction of proinflammatory cytokines by these cells are thought to be important in monocyte/macrophage activation<sup><xref rid="b2-kjim-19-1-70-14" ref-type="bibr">2</xref>)</sup>. Hypercytokinemia by these cells is important in the pathogenesis of HPS<sup><xref rid="b3-kjim-19-1-70-14" ref-type="bibr">3</xref>)</sup>. Known infectious agents that are associated with HPS include Epstein-Barr virus<sup><xref rid="b4-kjim-19-1-70-14" ref-type="bibr">4</xref>)</sup>, cytomegalovirus<sup><xref rid="b5-kjim-19-1-70-14" ref-type="bibr">5</xref>)</sup>, tuberculosis<sup><xref rid="b6-kjim-19-1-70-14" ref-type="bibr">6</xref>,<xref rid="b7-kjim-19-1-70-14" ref-type="bibr">7</xref>)</sup>, herpes simplex virus 6<sup><xref rid="b8-kjim-19-1-70-14" ref-type="bibr">8</xref>)</sup>, human immunodeficiency virus<sup><xref rid="b9-kjim-19-1-70-14" ref-type="bibr">9</xref>)</sup>, and leshimania<sup><xref rid="b10-kjim-19-1-70-14" ref-type="bibr">10</xref>)</sup>. However, there are no case reports described HPS associated with bilateral adrenal gland tuberculosis with combined adrenal crisis. We report the case of a patient who presented with HPS associated with bilateral adrenal gland tuberculosis.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 50-year-old man was transferred to our hospital from a local clinic due to fever and weight loss. The patient had been healthy until 15 days prior to his admission, when, at that time, he began to feel febrile, lost his sense of taste, and developed a poor appetite. The symptoms continued until the admission. Upon examination at the originating clinic, adrenal masses had been found on CT. On admission the patient&#x2019;s temperature was 37.7&#xB0;C, pulse 80 beats/min, respiration rate 20 breaths/min, and blood pressure 120/80 mmHg. On examination, the patient appeared ill and prostrated. Liver was palpable in 1 finger-breadth on the epigastric area and a 1.5&#xD7;1.0 cm sized firm and nontender right supraclavicular lymph node was palpated, but otherwise unremarkable. His leukocyte count was 1,700/&#x3BC;L with 65% neutrophils, hemoglobin 10.6 g/dL, and platelet 142,000/L. His blood chemistry revealed total serum protein was 6.3 g/dL, albumin 3.6 g/dL, aspartate transaminase 52 IU/L, alanine transaminase 29 IU/L, alkaline phosphatase 183 IU/L, sodium 129 mmol/L, potassium 4.0 mmol/L, lactate dehydrogenase (LDH) 1415 IU/L, and serum ferritin &gt;2000 ng/mL. The renal function was normal. Cortisol in the morning and evening was 17.8/20 &#x3BC;g/dL (normal range: 5 &#x2013; 25 &#x3BC;g/dL) and ACTH in the morning and evening 726/265 pg/dL (normal range: 10&#x2013;56.7 pg/dL). Serologic test for Epstein-Barr virus and cytomegalovirus were normal. Chest radiographs obtained on admission revealed normal findings, but a CT scan of the abdomen revealed bilateral adrenal masses and hepatosplenomegaly (<xref ref-type="fig" rid="f1-kjim-19-1-70-14">Figure 1</xref>). Right adrenal mass measured 6&#xD7;1.7 cm and the left was 8&#xD7;3 cm in size. CT-guided adrenal gland biopsy was done and showed numerous epithelioid cells and caseous necrosis consistent with tuberculosis (<xref ref-type="fig" rid="f2-kjim-19-1-70-14">Figure 2</xref>). But, an AFB stain of the tissue and polymerase chain reaction for <italic>Mycobacterium tuberculosis</italic> were negative. On subsequent bone marrow aspiration and biopsy, hemophagocytic histiocytes had increased in proportion (4.6%) without accompanying evidence of malignancy (<xref ref-type="fig" rid="f3-kjim-19-1-70-14">Figure 3</xref>), hence HPS associated with adrenal gland tuberculosis was diagnosed. Biopsy of the supraclavicular lymph node revealed necrosis, but no evidence of malignancy. Treatment with isoniazid, rifampin, ethambutol, and pyrazinamide was started immediately. On treatment day 4, the patient developed jaundice and elevated levels of transaminases. We discontinued hepatotoxic drugs (isoniazid, rifampin, pyrazinamide, and acetaminophen) and changed his medications to ethambutol, cycloserine, streptomycin, and ciprofloxacin. During the anti-tuberculous treatment the patient showed recurrent hypoglycemia and hypotension. Rapid ACTH stimulation test revealed adrenal insufficiency. Corticosteroid treatment was added. After supplementation with corticosteroid, the hypotension and hypoglycemia were corrected. After normalization of liver function, isoniazid was restarted with a gradual increase in dose. But pancytopenia progressed during the anti-tuberculous treatment. On treatment day 30, repeated bone marrow aspiration was performed and showed that numerous hemophagocytic histiocytes persisted (5.0%). On treatment day 41, the patient expired due to multiple organ failure (including disseminated intravascular coagulation, hepatic failure, and renal failure).</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>HPS is clinically characterized by fever, hepatosplenomegaly, pancytopenia (and associated complications, such as spontaneous bleeding or infection), coagulation disorders, and biochemical disturbances, such as hyperferritinemia, and elevated triglyceride and lactate dehydrogenase levels<sup><xref rid="b11-kjim-19-1-70-14" ref-type="bibr">11</xref>)</sup>. Risdall et al in 1979 described infection-associated HPS as a benign generalized histiocytic proliferation with marked hemophagocytosis associated with systemic viral infection<sup><xref rid="b12-kjim-19-1-70-14" ref-type="bibr">12</xref>)</sup>. Tuberculosis is a nonviral infection that can cause HPS, but only several cases have been reported<sup><xref rid="b6-kjim-19-1-70-14" ref-type="bibr">6</xref>,<xref rid="b7-kjim-19-1-70-14" ref-type="bibr">7</xref>)</sup>. Most of these patients had underlying disorders, such as chronic renal failure<sup><xref rid="b13-kjim-19-1-70-14" ref-type="bibr">13</xref>)</sup>, cancer<sup><xref rid="b14-kjim-19-1-70-14" ref-type="bibr">14</xref>)</sup>, diabetes<sup><xref rid="b15-kjim-19-1-70-14" ref-type="bibr">15</xref>)</sup>, and acquired immunodeficiency syndrome<sup><xref rid="b9-kjim-19-1-70-14" ref-type="bibr">9</xref>)</sup>, and their outcomes were poor. A relationship has been implied between systemic histiocytic proliferation and an underlying immunocompromised state, suggesting that immunologic disturbances occurring in infections could play a role in the pathogenesis of HPS<sup><xref rid="b16-kjim-19-1-70-14" ref-type="bibr">16</xref>)</sup>.</p>
      <p>The mechanism by which tuberculosis causes HPS is not known, but there are several possible explanations. Phagocytosis of mycobacteria by macrophages is the initial immune response to tuberculous infection. Some bacilli are killed within the macrophages, but others survive and replicate within their cellular hosts. In either case phagocytosis leads to cytokine production by the macrophages. Release of tumor necrosis factor (TNF)-&#x3B1;, interleukin (IL)-12, and other chemotactic cytokines perpetuates the host immune response and leads to the recruitment of lymphocytes, neutrophils, and monocytes. TNF-&#x3B1; leads to the fever and tissue wasting seen with both tuberculosis and hemophagocytic syndrome<sup><xref rid="b17-kjim-19-1-70-14" ref-type="bibr">17</xref>)</sup>. This cytokine, in conjunction with IL-12 and IL-5, leads to the migration of monocytes and macrophages to regional lymph nodes. This allows for the expansion of antigen-specific T cells, which in turn may lead to a secondary release of cytokines and increased proliferation and activation of phagocytes<sup><xref rid="b7-kjim-19-1-70-14" ref-type="bibr">7</xref>,<xref rid="b18-kjim-19-1-70-14" ref-type="bibr">18</xref>)</sup>. This process is presumably magnified in the setting of impaired cell-mediated immunity, which explains the increased prevalence of infection-associated HPS in patients with HIV infection and other forms of immunosuppression<sup><xref rid="b9-kjim-19-1-70-14" ref-type="bibr">9</xref>)</sup>.</p>
      <p>Because HPS is rare, no controlled clinical trials of therapy have been performed. For patients with HPS associated with pathogens other than Epstein-Barr virus, supportive care and treatment of the underlying infection is associated with recovery in 60&#x2013;70%. Among adults with HPS, age&gt;30 years appears to be associated with an increased risk for death<sup><xref rid="b19-kjim-19-1-70-14" ref-type="bibr">19</xref>)</sup>.</p>
      <p>In this case, on admission the patient had a subclinical adrenal insufficiency due to a reduction in the functioning adrenal tissues. In an adrenal function test, the cortisol level was within the normal range, but the ACTH (adrenocorticotropin) level was elevated highly. Because of the high possibility of adrenal crisis, early corticosteroid replacement was more reasonable than replacement after symptoms occurred. Ineffective control of HPS and tuberculosis by second line anti-tuberculous treatment might have allowed pancytopenia to persist for a longer duration, and might have contributed to hypercytokinemia and multiple organ failure. Because hypercytokinemia is the main pathophysiology of HPS, a cytokine reducing regimen may be essential in the acute phase. Several papers described the successful treatment of HPS using plasmapheresis<sup><xref rid="b20-kjim-19-1-70-14" ref-type="bibr">20</xref>,<xref rid="b21-kjim-19-1-70-14" ref-type="bibr">21</xref>)</sup>. Our patient&#x2019;s condition was refractory to corticosteroid and anti-tuberculous treatment. In such a refractory case, plasmapheresis may be considered to reduce cytokine and possibly improve the patient&#x2019;s clinical status in the acute phase.</p>
      <p>HPS associated with tuberculosis is a very rare disease and may resolve concurrent with tuberculosis treatment. However, early recognition and treatment are needed because of the possibility of a poor outcome.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="b1-kjim-19-1-70-14">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fisman</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>Hemophagocytic syndromes and infection</article-title>
          <source>Emerg Infect Dis</source>
          <volume>6</volume>
          <fpage>601</fpage>
          <lpage>608</lpage>
          <year>2000</year>
          <pub-id pub-id-type="pmid">11076718</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-kjim-19-1-70-14">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Imashuka</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment</article-title>
          <source>Int J Hematol</source>
          <volume>66</volume>
          <fpage>135</fpage>
          <lpage>151</lpage>
          <year>1997</year>
          <pub-id pub-id-type="pmid">9277044</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-kjim-19-1-70-14">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsuda</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fujisao</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Th1/Th2 milieu in adult hemophagocytic syndrome</article-title>
          <source>Acta Haematol</source>
          <volume>101</volume>
          <fpage>157</fpage>
          <lpage>160</lpage>
          <year>1999</year>
          <pub-id pub-id-type="pmid">10352337</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-kjim-19-1-70-14">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Imashuku</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis</article-title>
          <source>Crit Rev Oncol Hematol</source>
          <volume>44</volume>
          <fpage>259</fpage>
          <lpage>272</lpage>
          <year>2002</year>
          <pub-id pub-id-type="pmid">12467966</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-kjim-19-1-70-14">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aouad</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dan</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Alangaden</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Photo quiz: I. reactive hemophagocytic syndrome caused by CMV infection</article-title>
          <source>Clin Infect Dis</source>
          <volume>26</volume>
          <fpage>1295</fpage>
          <year>1998</year>
          <pub-id pub-id-type="pmid">9636849</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-kjim-19-1-70-14">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Basu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mohan</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Malhotra</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Pancytopenia due to hemophagocytic syndrome as the presenting manifestation of tuberculosis</article-title>
          <source>J Assoc Physicians India</source>
          <volume>48</volume>
          <fpage>845</fpage>
          <lpage>846</lpage>
          <year>2000</year>
          <pub-id pub-id-type="pmid">11273486</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-kjim-19-1-70-14">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Aoike</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Shibasaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Morita</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Miyazaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A successfully treated case of disseminated tuberculosis-associated hemophagocytic syndrome and multiple organ dysfunction syndrome</article-title>
          <source>Am J Kidney Dis</source>
          <volume>38</volume>
          <fpage>E19</fpage>
          <year>2001</year>
          <pub-id pub-id-type="pmid">11576906</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-kjim-19-1-70-14">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanaka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hakui</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sugimoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tanaka-Taya</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yamanishi</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Human herpesvirus 6-associated hemophagocytic syndrome in a healthy adult</article-title>
          <source>Emerg Infect Dis</source>
          <volume>8</volume>
          <fpage>87</fpage>
          <lpage>88</lpage>
          <year>2002</year>
          <pub-id pub-id-type="pmid">11749757</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-kjim-19-1-70-14">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pastore</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Godwin</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>HIV/AIDS case histories: diagnostic problems</article-title>
          <source>ADS Patient Care STDS</source>
          <volume>13</volume>
          <fpage>677</fpage>
          <lpage>678</lpage>
          <year>1999</year>
        </element-citation>
      </ref>
      <ref id="b10-kjim-19-1-70-14">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kontopoulou</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tsaousis</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vaidakis</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fanourgiakis</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Michalakeas</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Trigoni</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Samarkos</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Hemophagocytic syndrome in association with visceral leishmaniasis</article-title>
          <source>Am J Med</source>
          <volume>113</volume>
          <fpage>439</fpage>
          <lpage>440</lpage>
          <year>2002</year>
          <pub-id pub-id-type="pmid">12401543</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-kjim-19-1-70-14">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koduri</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Carandang</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>de Marais</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Hyperferritinemia in reactive hemophagocytic syndrome report of four adult cases</article-title>
          <source>Am J Hematol</source>
          <volume>49</volume>
          <fpage>247</fpage>
          <lpage>249</lpage>
          <year>1995</year>
          <pub-id pub-id-type="pmid">7604819</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-kjim-19-1-70-14">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Risdall</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>McKenna</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Nesbit</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Krivit</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Balfour</surname>
              <given-names>HH</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Simmons</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Brunning</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis</article-title>
          <source>Cancer</source>
          <volume>44</volume>
          <fpage>993</fpage>
          <lpage>1002</lpage>
          <year>1979</year>
          <pub-id pub-id-type="pmid">225008</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-kjim-19-1-70-14">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YG</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YO</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Bang</surname>
              <given-names>BK</given-names>
            </name>
          </person-group>
          <article-title>Tuberculosis-associated hemophagocytic syndrome in a hemodialysis patient: case report and review of the literature</article-title>
          <source>Nephron</source>
          <volume>72</volume>
          <fpage>690</fpage>
          <lpage>692</lpage>
          <year>1996</year>
          <pub-id pub-id-type="pmid">8730445</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-kjim-19-1-70-14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sakai</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shiraki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Deguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Itoh</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Konishi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takase</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Hepatocellular carcinoma associated with hemophagocytic syndrome</article-title>
          <source>Hepatogastroenterology</source>
          <volume>48</volume>
          <fpage>1464</fpage>
          <lpage>1466</lpage>
          <year>2001</year>
          <pub-id pub-id-type="pmid">11677988</pub-id>
        </element-citation>
      </ref>
      <ref id="b15-kjim-19-1-70-14">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Law</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>KF</given-names>
            </name>
          </person-group>
          <article-title>Reactive hemophagocytic syndrome: a study of 7 fatal cases</article-title>
          <source>Pathology</source>
          <volume>19</volume>
          <fpage>43</fpage>
          <lpage>50</lpage>
          <year>1987</year>
          <pub-id pub-id-type="pmid">3588026</pub-id>
        </element-citation>
      </ref>
      <ref id="b16-kjim-19-1-70-14">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Egeler</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Shapiro</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Loechelt</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Filipovich</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis</article-title>
          <source>J Pediatr Hematol Oncol</source>
          <volume>18</volume>
          <fpage>340</fpage>
          <lpage>345</lpage>
          <year>1996</year>
          <pub-id pub-id-type="pmid">8888739</pub-id>
        </element-citation>
      </ref>
      <ref id="b17-kjim-19-1-70-14">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Janka</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Imashuku</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Elinder</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Henter</surname>
              <given-names>JI</given-names>
            </name>
          </person-group>
          <article-title>Infection- and malignancy-associated hemophagocytic syndromes: secondary hemophagocytic lymphohistiocytosis</article-title>
          <source>Hematol Oncol Clin North Am</source>
          <volume>12</volume>
          <fpage>435</fpage>
          <lpage>444</lpage>
          <year>1998</year>
          <pub-id pub-id-type="pmid">9561911</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-kjim-19-1-70-14">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shaw</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shulman</surname>
              <given-names>ST</given-names>
            </name>
          </person-group>
          <article-title>Tuberculosis-associated hemophagocytic syndrome in an infant</article-title>
          <source>Pediatr Infect Dis J</source>
          <volume>19</volume>
          <fpage>475</fpage>
          <lpage>477</lpage>
          <year>2000</year>
          <pub-id pub-id-type="pmid">10819349</pub-id>
        </element-citation>
      </ref>
      <ref id="b19-kjim-19-1-70-14">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaito</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Katayama</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Otsubo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ogasawara</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sekita</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Saeki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sakamoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nishiwaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Masuoka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shimada</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hosoya</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases</article-title>
          <source>Eur J Haematol</source>
          <volume>59</volume>
          <fpage>247</fpage>
          <lpage>253</lpage>
          <year>1997</year>
          <pub-id pub-id-type="pmid">9338623</pub-id>
        </element-citation>
      </ref>
      <ref id="b20-kjim-19-1-70-14">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsumoto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Naniwa</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Banno</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sugiura</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>The efficacy of therapeutic plasmapheresis for the treatment of fatal hemophagocytic syndrome: two case reports</article-title>
          <source>Ther Apher</source>
          <volume>2</volume>
          <fpage>300</fpage>
          <lpage>304</lpage>
          <year>1998</year>
          <pub-id pub-id-type="pmid">10227760</pub-id>
        </element-citation>
      </ref>
      <ref id="b21-kjim-19-1-70-14">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sieberth</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Kierdorf</surname>
              <given-names>HP</given-names>
            </name>
          </person-group>
          <article-title>Is cytokine removal by continuous hemofiltration feasible?</article-title>
          <source>Kidney Int Suppl</source>
          <volume>72</volume>
          <fpage>S79</fpage>
          <lpage>S83</lpage>
          <year>1999</year>
          <pub-id pub-id-type="pmid">10560812</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-kjim-19-1-70-14" orientation="portrait" position="float">
      <label>Figure 1.</label>
      <caption>
        <p>CT of abdomen revealed bilateral adrenal masses with central necrosis.</p>
      </caption>
      <graphic xlink:href="kjim-19-1-70-14f1"/>
    </fig>
    <fig id="f2-kjim-19-1-70-14" orientation="portrait" position="float">
      <label>Figure 2.</label>
      <caption>
        <p>CT-guided adrenal gland biopsy shows numerous epithelioid cells and caseous necrosis consistent with tuberculosis.</p>
      </caption>
      <graphic xlink:href="kjim-19-1-70-14f2"/>
    </fig>
    <fig id="f3-kjim-19-1-70-14" orientation="portrait" position="float">
      <label>Figure 3.</label>
      <caption>
        <p>On bone marrow aspiration, mature histiocyte engulfing hematic cells is seen observed (5.0%).</p>
      </caption>
      <graphic xlink:href="kjim-19-1-70-14f3"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
